Sudeepa Bhattacharyya Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

High Impact

Researcher

Arkansas State University

faculty

26 h-index 114 pubs 3,077 cited

Research Areas

Mental Health Research Topics Gut microbiota and health Metabolomics and Mass Spectrometry Studies Neuroscience and Neuropharmacology Research Health disparities and outcomes Diet and metabolism studies Behavioral and Psychological Studies Natural Language Processing Techniques

Links

ORCID Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Sudeepa Bhattacharyya's research focuses on the intersection of mental health, the gut microbiome, and metabolic pathways. Her work investigates how alterations in metabolites, such as acylcarnitines, amines, lipids, and bile acids, are associated with the mechanisms of action of antidepressants and the pathobiology of major depression and anxiety. Bhattacharyya also explores the role of gut microbiome-derived uremic toxins, like indoxyl sulfate, in relation to psychological conditions and their neurologic signatures.

Her publications examine the influence of medication use on microbial features in anxiety and depression, and the association of acylcarnitine metabolism with diagnostic status, depression severity, and symptom profiles. Additionally, Bhattacharyya has contributed to research on the quality of social determinants of health data and the application of natural language processing techniques for comprehensive concept compilation.

Bhattacharyya holds a high-impact researcher designation due to her citation record. She has published over 114 works, with an h-index of 26 and more than 3,000 citations. She has served as Co-PI on an NSF grant for campus cyberinfrastructure modernization. Key collaborators include researchers from the University of Arkansas for Medical Sciences, such as Fred Prior, Kevin W. Sexton, Joseph VanScoy, and Shaymaa Al-Shukri.

Metrics

h-index: 26
Publications: 114
Citations: 3,077

Selected Publications

Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort (2025) DOI
Evaluating maternal drug use disparities, risk factors and outcomes in Northeast Arkansas: a pre, during, and post-COVID-19 pandemic analysis (2025) DOI
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder (2025) DOI
Medication use is associated with distinct microbial features in anxiety and depression (2025) DOI
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort (2024) DOI
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder (2024) DOI
Medication Use is Associated with Distinct Microbial Features in Anxiety and Depression (2024) DOI
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort (2024) DOI
Social Determinants of Health Data Quality at Different Levels of Geographic Detail (2023) DOI
Social Determinants of Health Data Quality at Different Levels of Geographic Detail (2023) DOI
Repeatable enhancement of healthcare data with social determinants of health (2022) DOI
Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids (2022) DOI
Covid-19 Positivity Differences Among Patients of a Rural, Southern US State Hospital System Based on Population Density, Rural-Urban Classification, and Area Deprivation Index (2022) DOI
Metabolomic and inflammatory signatures of symptom dimensions in major depression (2022) DOI
Automated Enhancement and Curation of Healthcare Data (2022) DOI